Patents by Inventor Marie-Therese Martin

Marie-Therese Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
    Patent number: 7758866
    Abstract: An immunogenic composition and methods for producing said composition, the composition comprising VLPs from HPV 16 and 18 and at least one other HPV cancer type, the other cancer type being selected from the list consisting of HPV types 31, 45 and 52, wherein the dose of the VLP of the at least one other cancer types is reduced relative to that of HPV 16 or 18.
    Type: Grant
    Filed: June 14, 2005
    Date of Patent: July 20, 2010
    Assignee: GlaxoSmithKline Biologicals, S.A.
    Inventors: Serge Debrus, Marie-Therese Martin, Robert John Stephen, Jean Stephenne, Martine Anne Cecile Wettendorff
  • Vaccine Against Hpv16 And Hpv18 And At Least Another Hpv Type Selected From Hpv 31, 45 Or 52
    Publication number: 20080014220
    Abstract: An immunogenic composition and methods for producing said composition, the composition comprising VLPs from HPV 16 and 18 and at least one other HPV cancer type, the other cancer type being selected from the list consisting of HPV types 31, 45 and 52, wherein the dose of the VLP of the at least one other cancer types is reduced relative to that of HPV 16 or 18.
    Type: Application
    Filed: June 14, 2005
    Publication date: January 17, 2008
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Serge Debrus, Marie-Therese Martin, Robert Stephen, Jean Stephenne, Martine Anne Wettendorff
  • Assay
    Publication number: 20070031828
    Abstract: A process for identification of type-specific polynucleotide sequences in a sample, the process comprising the steps of (1) contacting polynucleotides from the sample, or derived from the sample, with a plurality of type-specific probes in the context of a solid support, and detection of any type-specific hybridisation; and (2) contacting polynucleotides in the sample, or derived from the sample, with type-specific primers for those types capable of being detected by the hybridisation step in step 1, but not so detected, in a type-specific amplification reaction.
    Type: Application
    Filed: October 12, 2006
    Publication date: February 8, 2007
    Inventors: Brigitte Desiree Colau, Gary Dubin, Marie-Therese Martin, Wim Quint, Leen-Jan Van Doorn
  • Assay
    Publication number: 20050037352
    Abstract: A process for identification of type-specific polynucleotide sequences in a sample, the process comprising the steps of (1) contacting polynucleotides from the sample, or derived from the sample, with a plurality of type-specific probes in the context of a solid support, and detection of any type-specific hybridisation; and (2) contacting polynucleotides in the sample, or derived from the sample, with type-specific primers for those types capable of being detected by the hybridisation step in step 1, but not so detected, in a type-specific amplification reaction.
    Type: Application
    Filed: August 6, 2002
    Publication date: February 17, 2005
    Inventors: Brigitte Colau, Gary Dubin, Marie-Therese Martin, Wim Quint, Leen-Jan Van Doorn